Boston Scientific Neuromodulation Corporation: Device Recall
Recall #Z-2485-2025 · 06/06/2025
Recall Details
- Recall Number
- Z-2485-2025
- Classification
- Class II
- Product Type
- Device
- Recalling Firm
- Boston Scientific Neuromodulation Corporation
- Status
- Ongoing
- Date Initiated
- 06/06/2025
- Location
- Valencia, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 70,516
Reason for Recall
As a result of a comprehensive product performance review it was determine that the device and instruments are not consistently meeting expected performance levels. Issues include breakage of the instruments and implant/device.
Product Description
Superion IDS Kit Superion Indirect Decompression System 8MM, VF Implant 101-9808 00884662000529 Superion Indirect Decompression System 10MM, VF Implant 101-9810 00884662000536 Superion Indirect Decompression System 12MM, VF Implant 101-9812 00884662000543 Superion Indirect Decompression System 14MM, VF Implant 101-9814 00884662000550 Superion Indirect Decompression System 16MM, VF Implant 101-9816 00884662000567 Superion Indirect Decompression System Kit, VF Instrument 102-9800 00884662000574 The Vertiflex Procedure Instrument Platform, VF Instrument 140-9800 00884662000611 The Superion IDS Kit includes a set of proprietary instruments to deliver the Superion Implant in a minimally invasive manner. Instruments specifically designed for implanting the Superion Implant are sterile, single-use disposable instruments, consisting of a Dilator Assembly, Cannula Assembly, Interspinous Gauge, Inserter, Reamer, and Driver.
Distribution Pattern
U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.
Other Recalls by Boston Scientific Neuromodulation Corporation
- Class II: Risk 07/08/2025
- Class II: Risk 07/08/2025
- Class II: Risk 07/17/2024
- Class II: Risk 04/18/2024
View all recalls by Boston Scientific Neuromodulation Corporation →